{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:08:06Z","timestamp":1793387286829,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Kidney disease is a serious manifestation of systemic amyloidosis and a major cause of morbidity and mortality. Tuberculosis (TB) occurs up to 27 times more commonly in human immunodeficiency virus (HIV) infected patients and is also an important cause of renal amyloid; there are however no reports of renal amyloidosis in South Africa in the HIV era.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a retrospective record review of cases of amyloidosis diagnosed on renal biopsies at our tertiary referral hospital between January 1985 and December 2016.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Forty-six cases of amyloidosis were identified over the study period. The calculated biopsy prevalence was 1.38 per 100 non-transplant renal biopsies (95% Confidence Interval 1.02\u20131.86). AL amyloidosis was identified in 26 (57%) cases and AA in 20 (43%). The median age at presentation was 51\u2009years and 52% of cases were female. Patients with AA amyloidosis were significantly younger compared to their AL counterparts (age 42\u2009years vs. 58\u2009years,<jats:italic>p<\/jats:italic>\u2009=\u2009&lt;\u20090.001) and were all significantly non-white. The main clinical presentation was nephrotic syndrome (85%) and 52% of cases also had a serum creatinine value of greater than 120\u2009\u03bcmol\/L. Of the 20 cases of AA amyloidosis, 12 (60%) were associated with tuberculosis. HIV infection was noted in only two (10%) of the 20 AA cases. Median survival after diagnosis was 2 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Amyloidosis is a rare cause of kidney disease and typically presents with nephrotic syndrome. A similar number of AA and AL types were observed, and outcomes are worse in cases of AA amyloid. While TB remains the major underlying disease in this type, HIV infection was infrequent in cases of AA renal amyloidosis.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12882-019-1601-x","type":"journal-article","created":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T16:03:00Z","timestamp":1573315380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pattern of renal amyloidosis in South Africa"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7509-0755","authenticated-orcid":false,"given":"Muhammed","family":"Hassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Rafique","family":"Moosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,9]]},"reference":[{"issue":"12","key":"1601_CR1","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1681\/ASN.2006050460","volume":"17","author":"LM Dember","year":"2006","unstructured":"Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol. 2006;17(12):3458\u201371.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1601_CR2","first-page":"47","volume":"66","author":"G Mody","year":"1984","unstructured":"Mody G, Bowen R, Meyers OL. Amyloidosis at Groote Schuur Hospital, Cape Town. South African Med J. 1984;66(2):47\u20139.","journal-title":"South African Med J"},{"issue":"4","key":"1601_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.rce.2012.09.001","volume":"213","author":"D Real de As\u00faa","year":"2013","unstructured":"Real de As\u00faa D, Costa R, Contreras MM, Guti\u00e9rrez \u00c1, Filigghedu MT, Armas M. Clinical characteristics of the patients with systemic amyloidosis in 2000-2010. Rev Cl\u00ednica Espa\u00f1ola. 2013;213(4):186\u201393.","journal-title":"Rev Cl\u00ednica Espa\u00f1ola"},{"issue":"8","key":"1601_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/qjmed\/93.8.535","volume":"93","author":"N Joss","year":"2000","unstructured":"Joss N, McLaughlin K, Simpson K, Boulton-Jones JM. Presentation, survival and prognostic markers in AA amyloidosis. Qjm. 2000;93(8):535\u201342.","journal-title":"Qjm"},{"issue":"11","key":"1601_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/qjmed\/hcl092","volume":"99","author":"JO Connolly","year":"2006","unstructured":"Connolly JO, Gillmore JD, Lachmann HJ, Davenport A, Hawkins PN, Woolfson RG. Renal amyloidosis in intravenous drug users. Qjm. 2006;99(11):737\u201342.","journal-title":"Qjm"},{"issue":"1","key":"1601_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/ckj\/sfu117","volume":"8","author":"X Huang","year":"2015","unstructured":"Huang X, Wang Q, Jiang S, Chen W, Zeng C, Liu Z. The clinical features and outcomes of systemic AL amyloidosis: a cohort of 231 Chinese patients. Clin Kidney J. 2015;8(1):120\u20136.","journal-title":"Clin Kidney J"},{"issue":"23","key":"1601_CR7","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1056\/NEJMoa070265","volume":"356","author":"HJ Lachmann","year":"2007","unstructured":"Lachmann HJ, Goodman HJB, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356(23):2361\u201371.","journal-title":"N Engl J Med"},{"issue":"8","key":"1601_CR8","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1093\/ndt\/gfh890","volume":"20","author":"C Ensari","year":"2005","unstructured":"Ensari C, Ensari A, T\u00fcmer N, Ertug E. Clinicopathological and epidemiological analysis of amyloidosis in Turkish patients. Nephrol Dial Transplant. 2005;20(8):1721\u20135.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"1601_CR9","doi-asserted-by":"publisher","first-page":"950","DOI":"10.4103\/1319-2442.118094","volume":"24","author":"EWE Abdallah","year":"2013","unstructured":"Abdallah EWE. Incidence and clinical outcome of renal amyloidosis: a retrospective study. Saudi J Kidney Dis Transpl. 2013;24(5):950\u20138.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"October","key":"1601_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2147\/CLEP.S39981","volume":"6","author":"D Real de As\u00faa","year":"2014","unstructured":"Real de As\u00faa D, Costa R, Galv\u00e1n JM, Filigheddu MT, Trujillo D, Cadi\u00f1anos J. Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clin Epidemiol. 2014;6(October):369\u201377.","journal-title":"Clin Epidemiol"},{"issue":"3","key":"1601_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/13506129.2017.1342235","volume":"24","author":"T Lane","year":"2017","unstructured":"Lane T, Pinney JH, Gilbertson JA, Hutt DF, Rowczenio DM, Mahmood S, et al. Changing epidemiology of AA amyloidosis: clinical observations over 25 years at a single national referral Centre. Amyloid. 2017;24(3):162\u20136.","journal-title":"Amyloid"},{"issue":"8","key":"1601_CR12","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/eci.12097","volume":"43","author":"N Panizo","year":"2013","unstructured":"Panizo N, Rivera F, L\u00f3pez-G\u00f3mez JM. Spanish registry of glomerulonephritis. Decreasing incidence of AA amyloidosis in Spain. Eur J Clin Investig. 2013;43(8):767\u201373.","journal-title":"Eur J Clin Investig"},{"key":"1601_CR13","volume-title":"Global Tuberculosis Report","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Global Tuberculosis Report. 2017."},{"key":"1601_CR14","unstructured":"Statistics South Africa. Mortality and causes of death in South Africa, 2015: findings from death notification. Statistical Release P0309.3. Pretoria: Stats SA; 2017."},{"issue":"9693","key":"1601_CR15","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0140-6736(09)60916-8","volume":"374","author":"SS Abdool Karim","year":"2009","unstructured":"Abdool Karim SS, Churchyard GJ, Abdool Karim Q, Lawn SD. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet. 2009;374(9693):921\u201333.","journal-title":"Lancet"},{"issue":"10","key":"1601_CR16","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/sj.ki.5000351","volume":"69","author":"TE Gerntholtz","year":"2006","unstructured":"Gerntholtz TE, Goetsch SJW, Katz I. HIV-related nephropathy: a south African perspective. Kidney Int. 2006;69(10):1885\u201391.","journal-title":"Kidney Int"},{"key":"1601_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5414\/CNP86S117","volume":"86","author":"N Wearne","year":"2016","unstructured":"Wearne N, Okpechi IG. HIV-associated renal disease - an overview. Clin Nephrol. 2016;86 (2016)(13):41\u20137.","journal-title":"Clin Nephrol"},{"issue":"4","key":"1601_CR18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/ki.2008.604","volume":"75","author":"CM Wyatt","year":"2009","unstructured":"Wyatt CM, Morgello S, Katz-Malamed R, Wei C, Klotman ME, Klotman PE, et al. The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int. 2009;75(4):428\u201334.","journal-title":"Kidney Int"},{"issue":"1","key":"1601_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5414\/CNP72038","volume":"72","author":"M Nebuloni","year":"2009","unstructured":"Nebuloni M, Barbiano di Belgiojoso G, Genderini A, Tosoni A, LN R, et al. Glomerular lesions in HIV-positive patients: a 20-year biopsy experience from northern Italy. Clin Nephrol. 2009 Jul;72(1):38\u201345.","journal-title":"Clin Nephrol"},{"issue":"3","key":"1601_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/13506120701456293","volume":"14","author":"BH Miranda","year":"2007","unstructured":"Miranda BH, Connolly JO, Burns AP. Secondary amyloidosis in a needle phobic intra-venous drug user. Amyloid. 2007;14(3):255\u20138.","journal-title":"Amyloid"},{"issue":"1","key":"1601_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1471-2369-13-151","volume":"13","author":"O Jung","year":"2012","unstructured":"Jung O, Haack HS, Buettner M, Betz C, Stephan C, Gruetzmacher P, et al. Renal AA-amyloidosis in intravenous drug users \u2013 a role for HIV-infection? BMC Nephrol. 2012;13(1):151.","journal-title":"BMC Nephrol"},{"issue":"6","key":"1601_CR22","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1590\/S0037-86822011000600032","volume":"44","author":"GEB Silva","year":"2011","unstructured":"Silva GEB, Costa RS, Dantas M. Amiloidose secund\u00e1ria associada \u00e0 tuberculose numa bi\u00f3psia renal. Rev Soc Bras Med Trop. 2011;44(6):797.","journal-title":"Rev Soc Bras Med Trop"},{"key":"1601_CR23","unstructured":"Jennette JC, Olsen JL, Silva FG, D\u2019Agati VD. Renal Diseases Associated with Plasma Cell Dyscrasias, Amyloidoses, and Waldenstr\u00f6m Macroglobulinemia. In: Heptinstall\u2019s Pathology of the Kidney. 7th. Philadelphia: Lippincott Williams & Wilkin; 2015. 981."},{"key":"1601_CR24","volume-title":"Global Tuberculosis Report 2012","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Global Tuberculosis Report 2012. 2012."},{"key":"1601_CR25","unstructured":"UNAIDS. AIDSinfo [Internet]. AIDSinfo. 2016. Available from: http:\/\/aidsinfo.unaids.org\/ . [cited 2018 Aug 26]"},{"issue":"1","key":"1601_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/clinids\/14.1.189","volume":"14","author":"PJ Cozzi","year":"1992","unstructured":"Cozzi PJ, Abu-Jawdeh GM, Green RM, Green D. Amyloidosis in association with human immunodeficiency virus infection. Clin Infect Dis. 1992;14(1):189\u201391.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"1601_CR27","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1177\/0956462417694561","volume":"28","author":"J Denman","year":"2017","unstructured":"Denman J, Manavi K, Cook M. Lenalidomide as a treatment for relapsed AL amyloidosis in an HIV-positive patient. Int J STD AIDS. 2017;28(10):1045\u20137.","journal-title":"Int J STD AIDS"},{"key":"1601_CR28","unstructured":"Coelho S, Fernandes A, Soares E, Val\u00e9rio P, Farinha A, Nat\u00e1rio A, et al. Amyloidosis related to HIV \u2013 An unusual cause of nephrotic syndrome in HIV patients. Portuguese Journal of Nephrology & Hypertension 2017;31(September):207\u201311."},{"issue":"2","key":"1601_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4269\/ajtmh.2009.81.209","volume":"81","author":"S de Valli\u00e8re","year":"2009","unstructured":"de Valli\u00e8re S, Mary C, Joneberg JE, Rotman S, Bullani R, Greub G, et al. AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient. Am J Trop Med Hyg. 2009;81(2):209\u201312.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"1601_CR30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/ndt\/gfq427","volume":"26","author":"K El Karoui","year":"2011","unstructured":"El Karoui K, Vuiblet V, Dion D, Izzedine H, Guitard J, Frimat L, et al. Renal involvement in Castleman disease. Nephrol Dial Transplant. 2011;26(2):599\u2013609.","journal-title":"Nephrol Dial Transplant"},{"issue":"9651","key":"1601_CR31","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","volume":"372","author":"BM Mathers","year":"2008","unstructured":"Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733\u201345.","journal-title":"Lancet"},{"key":"1601_CR32","doi-asserted-by":"crossref","unstructured":"Fuster D, Cheng DM, Quinn EK, Armah KA, Saitz R, Freiberg MS, et al. Inflammatory cytokines and mortality in a cohort of HIV-infected adults with alcohol problems. 2015;28(7):1059\u201364.","DOI":"10.1097\/QAD.0000000000000184"},{"issue":"1","key":"1601_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1742-2094-10-113","volume":"10","author":"T Samikkannu","year":"2013","unstructured":"Samikkannu T, Rao KVK, Arias AY, Kalaichezian A, Sagar V, Yoo C, et al. HIV infection and drugs of abuse: role of acute phase proteins. J Neuroinflammation. 2013;10(1):113.","journal-title":"J Neuroinflammation"},{"issue":"11","key":"1601_CR34","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1093\/ndt\/gfg369","volume":"18","author":"M do Sameiro Faria","year":"2003","unstructured":"do Sameiro Faria M, Sampaio S, Faria V, Carvalho E. Nephropathy associated with heroin abuse in Caucasian patients. Nephrol Dial Transplant. 2003;18(11):2308\u201313.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"1601_CR35","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1681\/ASN.V1071566","volume":"10","author":"JT Cheng","year":"1999","unstructured":"Cheng JT, Anderson HL, Markowitz GS, Appel GB, Pogue VA, D\u2019Agati VD. Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection. J Am Soc Nephrol. 1999;10(7):1566\u201374.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1601_CR36","first-page":"1","volume":"12","author":"TT Jiang","year":"2017","unstructured":"Jiang TT, Shi LY, Wei LL, Li X, Yang S, Wang C, et al. Serum amyloid A, protein Z, and C4b-binding protein \u03b2 chain as new potential biomarkers for pulmonary tuberculosis. PLoS One. 2017;12(3):1\u201320.","journal-title":"PLoS One"},{"issue":"5","key":"1601_CR37","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3109\/00365548609032353","volume":"18","author":"A Husebekk","year":"1986","unstructured":"Husebekk A, Permin H, Husby G. Serum amyloid protein A (SAA): an indicator of inflammation in AIDS and AIDS-related complex (ARC). Scand J Infect Dis. 1986;18(5):389\u201394.","journal-title":"Scand J Infect Dis"},{"issue":"Suppl","key":"1601_CR38","doi-asserted-by":"publisher","first-page":"S361","DOI":"10.1086\/655965","volume":"202","author":"M Biasin","year":"2010","unstructured":"Biasin M, Clerici M, Piacentini L. Innate immunity in resistance to HIV infection. J Infect Dis. 2010;202(Suppl):S361\u20135.","journal-title":"J Infect Dis"},{"issue":"5","key":"1601_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1000893","volume":"6","author":"HB Kramer","year":"2010","unstructured":"Kramer HB, Lavender KJ, Qin L, Stacey AR, Liu MKP, di Gleria K, et al. Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection. PLoS Pathog. 2010;6(5):1\u201312.","journal-title":"PLoS Pathog"},{"key":"1601_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0959-440X(99)00049-4","volume":"10","author":"J Rochet","year":"2000","unstructured":"Rochet J, Lansbury PT Jr. Amyloid fibrillogenesis : themes and variations. Curr Opin Struct Biol. 2000;10:60\u20138.","journal-title":"Curr Opin Struct Biol"},{"issue":"4\u20135","key":"1601_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cytogfr.2012.05.005","volume":"23","author":"MA Reuter","year":"2012","unstructured":"Reuter MA, Pombo C, Betts MR. Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines. Cytokine Growth Factor Rev. 2012;23(4\u20135):181\u201391.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"23","key":"1601_CR42","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1056\/NEJMoa013354","volume":"346","author":"HJ Lachmann","year":"2002","unstructured":"Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, et al. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med. 2002;346(23):1786\u201391.","journal-title":"N Engl J Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1601-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1601-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1601-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T06:17:27Z","timestamp":1664864247000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1601-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,9]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1601"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1601-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,9]]},"assertion":[{"value":"18 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval was obtained from the Human Research Ethics Committee (HREC) of Stellenbosch University (protocol number S15\/02\/020) and the Chief Executive Officer of Tygerberg Hospital to conduct this study. In view of the retrospective nature of the study, waiver of patient consent was approved by the HREC.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. The results presented in this article have not been published previously in whole or part, except in abstract format.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"406"}}